EVRG vs LYRA · P/E 22, rev $5.96B vs rev $1.5M
Evergy, Inc. (EVRG) versus Lyra Therapeutics Inc (LYRA) — a side-by-side from cached financials, not a winner call.
Evergy, Inc. (EVRG) is a utilities - regulated electric company listed on NASDAQ.
Lyra Therapeutics Inc (LYRA) is a biotechnology company listed on US.
Latest reported EVRG revenue for 2025-12-31 was $5.96B. Net income was $855.6M. Revenue was up 2.0% from 2024-12-31 to 2025-12-31. EVRG currently screens at market cap $19.10B and trailing P/E 22.0.
Latest reported LYRA revenue for 2024-12-31 was $1.5M. Net income was -$93.4M. Revenue was down 1.5% from 2023-12-31 to 2024-12-31. LYRA currently screens at market cap $14.4M.
EVRG currently screens at market cap $19.10B and trailing P/E 22.0. LYRA currently screens at market cap $14.4M.
Not investment advice. Open the EVRG and LYRA stock pages for the full models.
Not investment advice.